Departments of Pediatrics and Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Allakos Inc., Redwood City, Calif.
J Allergy Clin Immunol Pract. 2021 May;9(5):2050-2059.e20. doi: 10.1016/j.jaip.2020.12.054. Epub 2021 Jan 10.
BACKGROUND: Eosinophilic gastritis and/or eosinophilic duodenitis (EG/EoD) is characterized by persistent symptoms and elevated eosinophils in the gastrointestinal tract. Limited disease awareness and lack of diagnostic guidelines suggest that patients may remain undiagnosed or endure diagnostic delay. OBJECTIVE: To characterize the path to diagnosis for patients with EG/EoD in a representative population. METHODS: In this observational cohort study, 4108 eligible patients diagnosed with EG/EoD between 2008 and 2018 were identified in an administrative claims database in the United States. Patient medical claim history was analyzed to describe events related to diagnosis. RESULTS: Mean year from symptom presentation to diagnosis of EG/EoD was 3.6; factors contributing to diagnostic delay included delayed gastroenterologist referral, delayed esophagogastroduodenoscopy (EGD), and lack of biopsy collection and/or histopathologic evaluation. Missed diagnosis on index EGD occurred in 38.2% of patients, resulting in a mean increase of 1.6 years in time to diagnosis versus patients diagnosed on index EGD. Patients presented with nonspecific symptoms and 44.3% were diagnosed with another gastrointestinal condition before EG/EoD diagnosis. Independent predictors of >2-year diagnostic delay included adult age; prior diagnosis of irritable bowel syndrome, functional dyspepsia, or gastric/peptic ulcer; use of other procedures such as colonoscopy; presence of edema; and history of certain allergic diseases. CONCLUSIONS: This study found that patients with EG/EoD experienced an average of 3.6 years between initial symptom presentation and diagnosis and revealed several factors contributing to diagnostic delay. We hope that these findings, together with heightened awareness and standardization of diagnostic guidelines, will improve the diagnostic journey of patients with EG/EoD.
背景:嗜酸性粒细胞性胃炎和/或嗜酸性粒细胞性十二指肠炎(EG/EoD)的特征是胃肠道中持续存在症状和嗜酸性粒细胞升高。由于对该病的认识有限且缺乏诊断指南,患者可能无法得到确诊或需要经历较长的诊断延迟。
目的:在具有代表性的人群中描述 EG/EoD 患者的诊断路径。
方法:在这项观察性队列研究中,在美国的一个行政索赔数据库中确定了 4108 名在 2008 年至 2018 年间确诊为 EG/EoD 的合格患者。分析了患者的医疗索赔记录,以描述与诊断相关的事件。
结果:从出现症状到 EG/EoD 确诊的平均时间为 3.6 年;导致诊断延迟的因素包括延迟的胃肠病专家转诊、延迟的食管胃十二指肠镜检查(EGD)以及缺乏活检采集和/或组织病理学评估。38.2%的患者在首次 EGD 时漏诊,导致与首次 EGD 确诊的患者相比,诊断时间平均增加 1.6 年。患者表现出非特异性症状,44.3%在 EG/EoD 确诊前被诊断为另一种胃肠道疾病。>2 年诊断延迟的独立预测因素包括成年;先前诊断为肠易激综合征、功能性消化不良或胃/消化性溃疡;使用其他程序,如结肠镜检查;存在水肿;以及某些过敏疾病的病史。
结论:本研究发现,EG/EoD 患者从最初出现症状到确诊平均经历了 3.6 年,并发现了导致诊断延迟的几个因素。我们希望这些发现,以及提高对该病的认识和诊断指南的标准化,将改善 EG/EoD 患者的诊断历程。
J Allergy Clin Immunol Pract. 2021-5
Clin Gastroenterol Hepatol. 2022-3
Clin Transl Gastroenterol. 2024-1-1
Immunol Allergy Clin North Am. 2024-5
Arch Pathol Lab Med. 2023-9-1
J Allergy Clin Immunol. 2023-4
Gastro Hep Adv. 2025-1-25
J Gen Fam Med. 2025-2-14
J Allergy Clin Immunol Glob. 2024-4-16